Drymiotou Stefania, Dokmeci Melin, Chandrasekaran Dhivya, Jeyarajah Arjun, Brockbank Elly
Gynaecology Oncology Department, Barts Health NHS Trust, London, UK.
Gynaecology Oncology Department, University College London Hospitals NHS Foundation Trust, London, UK.
Int J Med Robot. 2023 Jul 31:e2559. doi: 10.1002/rcs.2559.
The aim was to assess the surgical outcomes in obese women with endometrial cancer following robotic surgery introduction in a London tertiary gynaecological cancer unit.
Data was prospectively collected for 281 women undergoing endometrial cancer surgery in 2016, 2018 and 2019 (robotic surgery was introduced in November 2017).
The proportion of obese and morbidly obese patients undergoing minimally invasive surgery (MIS) significantly increased following robotic surgery introduction from 43.8% to 69.6% (p < 0.001). Overall robotic surgery operating time was not affected by higher body mass index (r = 0.177, 95% CI -0.068-0.402). There was no difference in the length of stay or in the frequency and severity of complication rates between obese, morbidly obese and non-obese populations undergoing MIS.
Robotic surgery led to a significant rise in MIS and improved surgical outcomes for obese and morbidly obese women with endometrial cancer within 12 months of its introduction.
目的是评估伦敦一家三级妇科癌症中心引入机器人手术后肥胖子宫内膜癌女性的手术效果。
前瞻性收集了2016年、2018年和2019年接受子宫内膜癌手术的281名女性的数据（机器人手术于2017年11月引入）。
引入机器人手术后，接受微创手术（MIS）的肥胖和病态肥胖患者比例从43.8%显著增加至69.6%（p<0.001）。总体机器人手术操作时间不受较高体重指数的影响（r = 0.177，95% CI -0.068 - 0.402）。接受MIS的肥胖、病态肥胖和非肥胖人群之间的住院时间、并发症发生率及严重程度无差异。
机器人手术引入后12个月内，显著提高了肥胖和病态肥胖子宫内膜癌女性的MIS率，并改善了手术效果。
